During the past decade, Kemerovo Regional Clinical Hospital conducted 41 clinical trials. In the 10-year time frame, 41 clinical trials started and 42 clinical trials were completed, i.e. on average, 102.4% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 19 clinical trials were completed. i.e. 118.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kemerovo Regional Clinical Hospital" #1 sponsor was "Hoffmann-La Roche" with 12 trials, followed by "Pfizer" with 11 trials sponsored, "Mannkind Corporation" with 8 trials sponsored, "Bayer" with 5 trials sponsored and "Eli Lilly and Company" with 5 trials sponsored. Other sponsors include 26 different institutions and companies that sponsored additional 23 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kemerovo Regional Clinical Hospital" #1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 2 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator, "OCT Clinical Trials" with 2 trials as a collaborator, "Takeda Development Center Americas, Inc." with 2 trials as a collaborator and "AbbVie" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Kemerovo Regional Clinical Hospital" are "Rheumatoid Arthritis" (8 trials), "Ulcerative Colitis" (6 trials), "Arthritis, Rheumatoid" (4 trials), "Crohn's Disease" (4 trials) and "Schizophrenia" (4 trials). Many other conditions were trialed in "Kemerovo Regional Clinical Hospital" in a lesser frequency.

Most popular intervention types in "Kemerovo Regional Clinical Hospital" are "Drug" (62 trials), "Biological" (8 trials), "Behavioral" (3 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (28 trials), "Technosphere Insulin" (5 trials), "Etrasimod" (4 trials), "Mirikizumab" (4 trials) and "Rituximab" (4 trials). Other intervention names were less common.

The vast majority of trials in "Kemerovo Regional Clinical Hospital" are 71 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Kemerovo Regional Clinical Hospital". undefined are not yet recruiting, 12 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 45 completed trials in Kemerovo Regional Clinical Hospital, undefined suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in Kemerovo Regional Clinical Hospital, 1 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 51 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 2 trials that are defined as “Not Applicable".